Australia · Health Care · AUD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average (own scale)
| Key metrics | Actual |
|---|
Amounts in AUD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for BIOTRON LIMITED? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Forecast |
|---|
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|
| Total Assets | A$493.48K | A$100.28K | A$100.28K | A$100.28K | A$100.28K | A$100.28K |
|---|---|---|---|---|---|---|
| Net Income | -A$3,436.52K | -A$3,435.94K | -A$3,743.35K | -A$4,135.34K | -A$4,581.00K | -A$5,130.15K |
| Sector average | -A$3,880.45K | -A$2,145.08K | -A$11,910.51K | -A$30,010.60K | -A$55,285.83K | -A$84,977.09K |